Dutasteride

Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

ITT-5 Mechanisms of Spermatogenesis in Man

Dutasteride to Treat Women With Menstrually Related Mood Disorders

Dutasteride Treatment for the Reduction of Heavy Drinking in Men

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects

AVODART® Alopecia Post-marketing Surveillance (PMS)

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia

TRADE-Testosterone Replacement and Dutasteride Effectiveness

ARI103094-Follow-Up Study for REDUCE Study Subjects